{
  "name" : "_cyber.sci-hub.se_MTAuMTAxNi9qLmFjdGJpby4yMDE1LjEyLjAwNg==_tang2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Bioinspired trimodal macro/micro/nano-porous scaffolds loading rhBMP-2 for complete regeneration of critical size bone defect",
    "authors" : [ "Wei Tang", "Dan Lin", "Yuanman Yu", "Haoyi Niu", "Han Guo", "Yuan Yuan", "Changsheng Liu" ],
    "emails" : [ "yyuan@ecust.edu.cn", "liucs@ecust.edu.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Contents lists available at ScienceDirect\nActa Biomaterialia\njournal homepage: www.elsevier .com/locate /actabiomat\nFull length article\nBioinspired trimodal macro/micro/nano-porous scaffolds loading rhBMP-2 for complete regeneration of critical size bone defect\nhttp://dx.doi.org/10.1016/j.actbio.2015.12.006 1742-7061/ 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.\n⇑ Corresponding authors. Address: Engineering Research Center for Biomaterials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China.\nE-mail addresses: yyuan@ecust.edu.cn (Y. Yuan), liucs@ecust.edu.cn (C. Liu).\nWei Tang a,c, Dan Lin b,c, Yuanman Yu a,c, Haoyi Niu c, Han Guo d, Yuan Yuan c,⇑, Changsheng Liu a,b,c,⇑ a The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, PR China bKey Laboratory for Ultrafine Materials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China cEngineering Research Center for Biomaterials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China d Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, PR China\na r t i c l e i n f o a b s t r a c t\nArticle history: Received 30 June 2015 Received in revised form 30 November 2015 Accepted 2 December 2015 Available online 12 December 2015\nKeywords: Trimodal macro/micro/nano-porous architecture Recombinant human bone morphogenetic protein-2 Critical size bone defect Mesoporous bioactive glass\nCritical size bone defects raise great demands for efficient bone substitutes. Mimicking the hierarchical porous architecture and specific biological cues of natural bone has been considered as an effective strategy to facilitate bone regeneration. Herein, a trimodal macro/micro/nano-porous scaffold loaded with recombinant human bone morphogenetic protein-2 (rhBMP-2) was developed. With mesoporous bioactive glass (MBG) as matrix, a trimodal MBG scaffold (TMS) with enhanced compressive strength (4.28 MPa, porosity of 80%) was prepared by a ‘‘viscosity controlling” and ‘‘homogeneous particle reinforcing” multi-template process. A 7.5 nm, 3D cubic (Im3m) mesoporous structure was tailored for a ‘‘size-matched entrapment” of rhBMP-2 to achieve sustained release and preserved bioactivity. RhBMP-2-loaded TMS (TMS/rhBMP-2) induced excellent cell attachment, ingrowth and osteogenesis in vitro. Further in vivo ectopic bone formation and orthotopic rabbit radius critical size defect results indicated that compared to the rhBMP-2-loaded bimodal macro/micro- and macro/nano-porous scaffolds, TMS/rhBMP-2 exhibited appealing bone regeneration capacity. Particularly, in critical size defect, complete bone reconstruction with rapid medullary cavity reunion and sclerotin maturity was observed on TMS/rhBMP-2. On the basis of these results, TMS/rhBMP-2 developed here represents a promising bone substitute for clinical application and the concepts proposed in this study might provide new thoughts on development of future orthopedic biomaterials.\nStatement of Significance\nLimited self-regenerating capacity of human body makes the reconstruction of critical size bone defect a significant challenge. Current bone substitutes often exhibit undesirable therapeutic efficacy due to poor osteoconductivity or low osteoinductivity. Herein, TMS/rhBMP-2, an advanced mesoporous bioactive glass (MBG) scaffold with osteoconductive trimodal macro/micro/nano-porosity and osteoinductive rhBMP-2 delivery was developed. The preparative and mechanical problems of hierarchical MBG scaffold were solved without affecting its excellent biocompatibilities, and rhBMP-2 immobilization in sizematched mesopores was first explored. Combining structural and biological cues, TMS/rhBMP-2 achieved a complete regeneration with rapid medullary cavity reunion and sclerotin maturity in rabbit radius critical size defects. The design conceptions proposed in this study might provide new thoughts on development of future orthopedic biomaterials.\n2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.\n1. Introduction infection, as an extreme medical scenario, have raised significant\nCritical size bone defects resulting from nonunion fractures, severe trauma, congenital deficiency, malignancy resection or\nclinical challenges worldwide [1,2]. Autograft remains the gold standard in orthopedic surgery due to its excellent osteoinductive and osteoconductive capability, yet limited tissue availability, donor site morbidity and additional surgical pain restrict their clinical applications [3,4]. As a sub-optimal alternative, allografts have considerable deficiencies, such as relatively low osteoinductivity compared to autografts, risks of immune rejection and disease\ntransmission [5,6]. These complications necessitate the pursuit of synthetic substitutes for treatment of these formidable defects. Unfortunately, current available bone substitutes often exhibit either poor ‘‘osteoconductivity” or limited ‘‘osteoinductivity”, resulting in undesirable therapeutic efficacy [7,8]. Therefore, development of advanced bone substitutes with excellent osteogenic capability that can support damaged tissue, induce osteogenic differentiation and re-establish original geometry and function of the impaired tissue is highly desired.\nInspired by the impressive property of natural bone, three-dimensional hierarchical porous scaffolds, which can provide transportation ‘‘highways” on various scales during osteo-regeneration, and promote the innate regenerative mechanisms of the human body, have attracted significant attention [9,10]. In recent years, synthetic scaffolds with hierarchical macro/micro- or macro/nano-architectures are being rapidly developed and have evolved various biomaterials, including biodegradable polymers (tyrosine-derived polycarbonate, poly(D,\nL-lactide-co-glycolide) [11–13], ceramics (hydroxyapatite, bioglass) [14–16] and metals (stainless steel, titanium) [17,18], etc. Numerous studied have concluded that interconnected macroporosity with diameter larger than 100 lm is a prerequisite for bone ingrowth, cellular infiltration and nutrient/waste transportation [19,20]; and micro- and nano-topologies on the material surface play a critical role on cell attachment, biomineralization and fullscale osteointegration in vivo [21–23]. Based on these previous researches, we believe that it will be an inevitable trend to incorporate these macro/micro/nano-scale structures into one scaffold to achieve optimal osteogenic properties. Mesoporous bioactive glass (MBG), due to its unique mesoporous structure and excellent bioactivity has been widely developed as hierarchical bone substitutes. However, the current reports were mainly focused on bimodal macro/nano- and micro/nano-scaffold [24,25], only one literature to date has reported a trimodal macro/micro/nanoporous scaffold for bone tissue engineering based on MBG [26]. Being limited by current fabrication technologies, this trimodal porous MBG scaffold was too brittle to handle in further in vitro and in vivo applications.\nAnother clinical strategy to accelerate tissues regeneration is the incorporation of growth factors [27,28]. In particular, bone morphogenetic protein-2 (BMP-2), a potent osteoinductive growth factor, has been considered as the most notable cytokine to enhance bone formation [29,30]. However, delivery of recombinant human BMP-2 (rhBMP-2) at a low and therapeutically efficient dose with sustained release kinetics remains a challenge. So far, strategies for rhBMP-2 immobilization include covalent and non-covalent immobilization, which often lead to protein denaturation and relatively unsatisfactory loading/releasing capacities [31–33]. Entrapment in mesopores has turned out to be a promising strategy in the fields of enzymatic biocatalysis and biosensors etc., and some researches have reported that the mesoporous support with comparable porous size to the protein molecule is beneficial for higher loading, preserved activity and sustained release [34,35]. Motivated by these previous investigations, we proposed the concept of ‘‘size-matched mesoporous entrapment” for rhBMP-2 delivery and endeavored to investigate the possibility of matching the mesoporous dimension with the size of rhBMP-2 molecule (7 3.5 3 nm3) to achieve a desirable immobilization, and further realize optimal bone regeneration by cooperation of multiscale structure and rhBMP-2.\nBased on the above rationale, this study aimed to develop a mechanical stable hierarchical macro/micro/nano-porous scaffold loading rhBMP-2 for regeneration of large segmental bone defects. As depicted in Fig. 1A, the trimodal porosity of the scaffold included highly interconnected macropores (200–500 lm), osteogenesis-related micropores (<10 lm) and rhBMP-2entrapped mesopores ( 7.5 nm). This bioinspired system can provide biomimetic microenvironment combining osteoconductivity and osteoinductivity on different scales. To achieve this, with MBG as matrix, a ‘‘viscosity controlling” and ‘‘homogeneous particle reinforcing” multi-template method was proposed for fabrication of the robust trimodal MBG scaffold (TMS, Fig. 1B). And a size-matched and accessible mesoporous structure was tailored for protein entrapment. To investigate the cooperation of trimodal porous structure and rhBMP-2 in promoting bone regeneration in vivo, ectopic bone formation in thigh muscle pouches of mice\nfor accelerated bone regeneration. (B) Schematic illustration of preparing trimodal ng” and ‘‘homogeneous particle reinforcing” processes.\nand orthotopic bone formation in rabbit radius critical size defect were systematically studied. For comparison, bimodal scaffolds with macro/nano-porous structure (BMS-N) and macro/microporous structure (BMS-M) were also prepared (where ‘‘N” and ‘‘M” represent ‘‘nano” and ‘‘micro” respectively)."
    }, {
      "heading" : "2. Materials and methods",
      "text" : ""
    }, {
      "heading" : "2.1. Materials",
      "text" : "F127 (EO106PO70EO106), methyl cellulose, Alizarin Red S, 2-(4- Amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI), tetracycline, calcein, fluorescein isothiocyanate-Phalloidin (FITCPhalloidin) and human BMP-2 ELISA kit were from Sigma–Aldrich (St. Louis, MO, USA). Tetraethyl orthosilicate (TEOS) and triethyl phosphate (TEP) were from Shanghai Ling Feng Chemical Reagent Co., Ltd. (Shanghai, China). Ethanol and Ca(NO3)2 4H2O were from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). Polyurethane (PU) sponge was from Freudenberg (Suzhou, China). Live/ Dead Cell Double Staining Kit and anti-CD31 antibody were purchased from Abcam (Cambridge, UK). BCA protein assay kit and BCIP/NBT alkaline phosphatase color development kit were purchased from Beyotime Institute of Biotechnology (Shanghai, China). RhBMP-2 (26 kD) was generously provided by Shanghai Rebone Biomaterials Co., Ltd. (Shanghai, China). Trizol reagent, PrimeScript RT reagent kit and SYBR Premix Ex TaqTM were from Takara Biotechnology Co., Ltd. (Dalian, China). All reagents used in cell culture were from Gibco (Grand Island, NY, USA)."
    }, {
      "heading" : "2.2. Synthesis of TMS",
      "text" : "TMS was prepared by a modified multi-template (mesoporous template: F127, microporous template: methyl cellulose, macroporous template: PU sponge) method with MBG particles as a selfreinforcing agent. In a typical evaporation induced self-assembly (EISA) synthesis, 4.0 g of F127, 1.0 g of HCl (0.5 M), 0.76 g of Ca (NO3)2 4H2O, 0.23 g of TEP and 5.2 g of TEOS were dissolved in 50 mL of ethanol and stirred at 30 C for 1 d. The resulting sol was rotary evaporated under vacuum condition at 60 C for 30 min to achieve an optimal viscosity of 4.0 104–6.0 104 mPa s. Part of the resulting sol was dried, ball-milled and sieved to achieve uniform MBG particles as a self-reinforcing agent (about 10 lm). Subsequently, methyl cellulose (ethanol-insoluble microsphere) and MBG particles were mixed into the rest of the sol to form an uniform slurry (specific preparative proportions are listed in Table 1), which was then impregnated into the macroporous template (PU sponge) by one-step casting. After dried, a heat treatment program (600 C for 5 h, ramp of 1 C min 1) was applied to remove all templates and obtain the final TMS.\nDifferent porosities of the scaffolds could be modulated by altering the ratio of impregnated slurry amount and sponge volume. Altering the mass volume ratio from 0.45 g cm 3 to 0.9 g cm 3, the corresponding porosities could be modulated from 90% to 60%. For better cell penetration and tissue ingrowth, the porosity of 80% (mass volume ratio of 0.55 g cm 3) was applied\nin this work. For the purpose of comparison, bimodal scaffold with macro/nano-porous structure (BMS-N) and macro/micro-porous structure (BMS-M) were also prepared by similar procedures without adopting micro-template or nano-template."
    }, {
      "heading" : "2.3. Scaffold characterization",
      "text" : "Interconnected macroporous network of the scaffold was characterized by synchrotron radiation-based micro-CT (SRlCT) at BL13W of Shanghai Synchrotron Radiation Facility (SSRF, Shanghai, China) using a monochromatic beam with energy of 20 keV and a sample-to-detector distance of 0.5 m. Scanning electron microscopy (SEM, S-3400, Hitachi, Japan) was performed to explore the detailed microstructure of scaffold. The ordered mesoporous structure of scaffold was confirmed by small angle X-ray diffraction (SAXRD, Rigaku D/max-2200, Rigaku, Japan) and transmission electron microscope (TEM, JEM-2100F, JEOL, Japan). Brunauere–Emm ette–Teller (BET) and Barrete–Joynere–Halenda (BJH) analyses were used to determine the surface area and the mesopore size distribution with a Micromeritics porosimeter (Tristar 3000, Micromeritics, USA)."
    }, {
      "heading" : "2.4. Mechanical strength",
      "text" : "The compressive strengths of the scaffold specimens (size of 10 10 10 mm3) were measured by a universal testing machine (AG-2000A, Shimadzu, Japan) at a constant loading rate of 1 mmmin 1."
    }, {
      "heading" : "2.5. RhBMP-2 immobilization",
      "text" : "It’s well recognized that ‘‘Ca is loosely bound to the silica”, thus in a traditional soaking immobilization process, ‘‘during the immobilization of rhBMP-2, Ca ions would be largely released” [9,16]. Commonly, traditional strategy involves immersing the scaffold into rhBMP-2 solution, which not only results in ion release of scaffold, but also leads to an uncontrollable immobilization amount. To avoid such change in composition and physicochemical properties of the scaffold, we adopted a ‘‘saturated volume adsorption” strategy for rhBMP-2 immobilization instead of traditional soaking method. First, saturated adsorption volumes of scaffolds were measured using deionized water. Then fixed amount of rhBMP-2 was dissolved into PBS of the corresponding volume. This volume was extremely low (below 1 lL mm 3, which was far below the soaking volume used in traditional way, see Table 2), and would not affect the properties of the scaffold. Afterwards, this volume of rhBMP-2 solution was added dropwise to each sterilized scaffold (sterilized by Co-60 gamma irradiator) and vacuum-freeze-dried at 40 C overnight. Scaffolds immobilized with rhBMP-2 will be referred to as TMS/rhBMP-2, BMS-N/rhBMP-2 and BMS-M/ rhBMP-2. In this study, SAXRD was characterized to provide indirect evidence that rhBMP-2 had been immobilized into mesopores.\nMS.\nTable 2 Parameters of rhBMP-2 immobilization.\nApplication Scaffold Shape and size Saturated adsorption volume of scaffold (lL)\nrhBMP-2 amount (lg)\nCell culture Cuboid (10 mm 10 mm 3 mm) 250 1.0 Ectopic bone formation Cylinder (£ 2 mm 5 mm) 15 5.0 In vitro release study & Orthotopic bone formation Cylinder (£ 5 mm 16 mm) 250 50.0"
    }, {
      "heading" : "2.6. Cell culture and seeding",
      "text" : "Rat bone marrow stromal cells (rBMSCs) were extracted from rat bone marrow. Both ends of the rat femur were cut away from the epiphysis. Bone marrow was flushed out with complete culture medium, 15 mL a-MEM containing 10% fetal bovine serum (FBS) and 1% antibiotics (100 U mL 1 penicillin G and 100 lg mL 1 streptomycin sulfate). The bone marrow suspension was poured into a 75 cm2 tissue culture polystyrene flask and incubated at 37 C in a humidified atmosphere containing 5% CO2. The culture medium was refreshed every 2 d until about 90% confluence was achieved.\nHuman umbilical vein endothelial cells (HUVECs) were purchased from the American Type Culture Collection (ATCC) and cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 10% FBS and 1% antibiotics at 37 C, 5% CO2, in a humidified environment.\nCell seeding onto scaffolds: Before seeding, scaffolds were placed at the bottom of each well (24-well) and pre-soaked in complete culture medium for 24 h to avoid the effects of pH variation on cell culture and facilitate the uniform cells distribution. Then 100 lL cells suspension was seeded on each sample and incubated for 2 h to allow cell attachment. Afterwards, 900 lL of culture medium was added to each well. Different cell density and further treatment would be applied according to various experiments as described later in this article."
    }, {
      "heading" : "2.7. RhBMP-2 release behavior and bioactivity maintenance",
      "text" : "In vitro rhBMP-2 release profiles of the scaffolds were investigated. Briefly, rhBMP-2-loaded scaffolds were placed in test tubes and immersed in 2 mL of PBS (pH = 7.4) at 37 C under a constant vibration of 30 rpm. At each time point, the supernatant was collected and replaced with an equal amount of fresh PBS. The amounts of released rhBMP-2 were quantitatively analyzed using a Human BMP-2 ELISA kit to plot the release profiles.\nTo characterize protein structural maintenance by mesopores, circular dichroism (CD) measurement (J-715, Jasco, Japan) and CD spectra deconvolution software CDNN was applied to investigate the differences in secondary structure between free rhBMP-2 and TMS-released rhBMP-2.\nALP activity was determined to evaluate the activity of rhBMP-2 released from TMS. After quantitatively analyzed by a human BMP-2 ELISA kit, the supernatants were used to prepare an osteoinductive culture medium containing 10% FBS and 1 lg mL 1 TMS-released rhBMP-2. Culture media with 1 lg mL 1 free rhBMP2 and without rhBMP-2 were set for reference and blank control respectively. RBMSCs were seeded at a density of 2 104 cells/well and 24 h post-seeding the medium was changed to the aforementioned culture media. After 3 and 7 days of culture, the medium was removed and washed with PBS twice, followed by 200 lL of Nonidet P-40 (NP-40, 1%) solution added to each well at room temperature. Samples were incubated for 1 h to obtain cell lysates. Then 50 lL of the cell lysates from each sample was pipetted to 96-well plates. 50 lL of p-nitrophenyl phosphate substrate solution (pNPP, 2 mg mL 1, Sigma, USA), containing 0.1 mol L 1 of glycine and 1 mmol L 1 of MgCl2 6H2O was added and incubated\nfor 2 h at 37 C, the reaction was quenched by adding 100 lL of NaOH (0.1 mol L 1) and ALP activity was quantified by the absorbance at a wavelength of 405 nm using enzyme-linked immunoadsorbent assay plate reader (SpectraMax Plus 384, Molecular Devices, USA). The total protein content of each cell lysate was determined using a BCA protein assay kit. ALP levels were normalized with total protein content."
    }, {
      "heading" : "2.8. Cell osteogenic differentiation assay",
      "text" : "Osteogenic gene expression analyses were performed using BioRad real-time quantitative reserve transcription-polymerase chain reaction (RT-qPCR) system (CFX96, Bio-Rad, USA). RBMSCs were seeded on scaffolds at a density of 5 104 cells/well. After 3, 7 and 10 days of culture, total RNA was extracted using Trizol reagent from cells. The concentration of RNA was determined by measuring optical absorbance of the extract at 260 nm. First strand complementary DNA (cDNA) was synthesized from 2 lg RNA using PrimeScript RT reagent kit (Takara, Tokyo, Japan) following manufacturer’s instructions. RT-qPCR was carried out in 20 lL of reaction volume containing 10 lL of SYBR Premix Ex TaqTM, 0.4 lL each of 50 lM forward and reverse primers, 1 lL of cDNA template diluted 1:5, and 8.2 lL of RNase free water. Osteogenic differentiation markers: runt-related transcription factor 2 (Runx2), bone sialoprotein (BSP), osteopontin (OPN) and osteocalcin (OCN) were evaluated, with GAPDH gene used as house keeping gene. Cultures without scaffolds were set as blank control. Relative expression level for each gene (fold change) to that of blank control group was calculated. All experiments were performed in quadruplicates. Primer sequences used in this study were listed in Table S1.\nALP staining and mineralization of rBMSCs on TMS, TMS/ rhBMP-2, BMS-N/rhBMP-2 and BMS-M/rhBMP-2 were evaluated at day 7 and 10, respectively. Following fixation, cells were stained with BCIP/NBT alkaline phosphatase color development kit and Alizarin Red. Cultures without scaffolds were set as blank control. Culture medium with the same amount of free rhBMP-2 (1 lg mL 1) was set for reference."
    }, {
      "heading" : "2.9. Cell viability, penetration and attachment",
      "text" : "Scaffold toxicity was evaluated by live/dead assay. RBMSCs were seeded on TMS at a density of 5 104 cells/well. After 24 h incubation, cells were fixed with 2.5% glutaraldehyde solution and stained with live/dead double staining kit. For cell morphology and spreading observation, rBMSCs and HUVECs (5 104 cells/ well) were used as models to evaluate the cell behavior. After 24 h incubation, cells were fixed and incubated with FITCPhalloidin (5 lg mL 1) and DAPI (5 lg mL 1) for cytoskeleton and cellular nuclei staining. Cell morphology and spreading were observed using confocal laser-scanning microscopy (CLSM, Nikon A1, Nikon, Japan).\nDetailed rBMSCs morphology on scaffold was further observed by SEM. After 12 h incubation, cells were fixed and dehydrated in ascending concentrations of ethanol (50, 70, 80, 90, 95 100, v/v%, 5 min at each gradient), followed by immersing in isoamyl acetate for 20 min and vacuum-dried at 37 C for 4 h."
    }, {
      "heading" : "2.10. Surgical procedures",
      "text" : "Ectopic bone formation of TMS/rhBMP-2, BMS-N/rhBMP-2 and BMS-M/rhBMP-2 in thigh muscle pouches of mice was studied. Forty-two male C57BL/6 mice (Slac Laboratory Animal Co., Ltd. Shanghai, China) with an average weight of 25 g were used and randomly divided into 3 groups. At week 2 and 4, animals were sacrificed with an overdose of pentobarbital and the implants were retrieved. Four specimens from each group were weighed for both wet bone and ash content (calcinated at 800 C for 4 h), and others were sectioned for histological analysis and immunohistochemistry.\nFor orthotopic study, rabbit radius critical size segmental defect model was established. Eighty 5-month-old New Zealand white rabbits (National Tissue Engineering Center, Shanghai, China) with an average weight of 3 kg were used and randomly divided into four groups: TMS, TMS/rhBMP-2, BMS-N/rhBMP-2 and BMS-M/ rhBMP-2. The NZW rabbits were anesthetized by intramuscular injection of ketamine (10 mg kg 1 body weight). The mid-shaft of the left radius was exposed through a lateral longitudinal skin incision and a section of the diaphysis (16 mm) was cut off using a dental drill with rinsing of 0.9% saline. The bone defect was filled with a prepared cylinder scaffold. With the encapsulation of deep muscle layer, the operative site did not need external fixation after skin sutured and covered by sterile gauze. After the surgery, the rabbits were individually caged and fed. At week 2, 4, 8 and 12, the rabbits were sacrificed successively to obtain the bony specimens. All procedures were carried out following approval of Institutional Animal Care and Use Committee of National Tissue Engineering Center (Shanghai, China)."
    }, {
      "heading" : "2.11. Micro-CT assay and biomechanical testing",
      "text" : "Shanghai Showbio Biotech was commissioned to perform micro-CT characterization. The retrieved radius bone specimens were scanned by Skyscan 1076 (Bruker microCT, USA). A voltage of 40 kV and current of 250 lA were used in all scans at a resolution of 35 lm. The images were reconstructed and analyzed by SkyScan CTVOX 2.1. In present study, a cylinder area (16 mm in height, illustrated in Fig. 6A) with the defect site of radius in the center was selected as region of interests (ROI) for quantifications of bone mineral density (BMD), bone volume/total volume (BV/TV), trabecular thickness (Tb.Th) and trabecular number (Tb.N). Strength of three-point bending of the experimental radius at week 12 was measured with normal radius as control."
    }, {
      "heading" : "2.12. Sequential fluorescent labeling",
      "text" : "A polychrome sequential labeling method for labeling mineralized tissue was carried out to evaluate the time course of new bone formation and mineralization in the critical size defect. Briefly, 25 mg kg 1 tetracycline and 20 mg kg 1calcein were injected at week 2 and 4 respectively, and then the animals were sacrificed to obtain the bony specimens. Similar sequential fluorescent labeling was carried out at week 6 and 8. At last, 25 mg kg 1 TE was administered at week 10 and the rabbits were sacrificed at week 12. Then, the obtained specimens were cut into 150 lm thick slices using a microtome, followed by ground and polished to a final thickness of about 40 lm. The undecalcified sections were observed for fluorescent labeling under CLSM. The excitation/emission wavelengths used to visualize each of the fluorophores were as follows: 405/580 nm (tetracycline, yellow) and 488/517 nm (calcein, green). As different fluorescence in the images represent the newly mineralized bone deposition of different times, the defect site regions were chosen to quantify the fluorescencelabeled areas, which reflect the formation of new bone during\nthe corresponding periods. The rate of new bone mineralization between two time points was calculated by measuring the distance between two corresponding fluorescent stripes and dividing it by time. The above graphic quantifications were analyzed by Image Pro Plus. In addition, the undecalcified sections were counterstained with Van Gieson’s picro fuchsin (VG) to observe the mineralized bone tissue microscopically."
    }, {
      "heading" : "2.13. Histological and Immunohistochemistry analysis",
      "text" : "After fixation with 4% neutral buffered formalin, the extracted bones were decalcified in 12.5% EDTA, dehydrated in a graded series of alcohol, and embedded in paraffin. Serial 4 lm thick sections were stained with Masson’s trichrome and hematoxylin/eosin (HE), and observed microscopically.\nAfter fixation and decalcification, the ectopic bone sections were deparaffined and incubated with a primary antibody against CD31 (1:50 dilution), following incubation with a secondary antibody, and DAB substrate was used to stain the slides. The sections were then treated with hematoxylin and mounted."
    }, {
      "heading" : "2.14. Statistical analysis",
      "text" : "Results were expressed as mean ± SD (standard deviation). All data were generated from four or five independent experiments. Statistical analysis was conducted using one-way ANOVA with post hoc tests. A value of p < 0.05 was considered statistically significant."
    }, {
      "heading" : "3. Results",
      "text" : ""
    }, {
      "heading" : "3.1. Structural and mechanical properties of scaffolds",
      "text" : "To construct a trimodal macro/micro/nano-porous MBG scaffold with adequate strength to support in vivo load bearing, a ‘‘viscosity controlling” and ‘‘homogeneous particle reinforcing” multi-template method was developed. As illustrated in Fig. 1B, through an evaporation-induced self-assembly (EISA) process, MBG sol was synthesized with F127 as a mesoporous template, followed by rotary evaporation to achieve a specific viscosity. Part of the resulting viscous sol was dried, ball-milled and sieved to achieve uniform MBG particles (particle size 10 lm). Methyl cellulose as a microporous hard template and MBG particles as a selfreinforcing agent were mixed into the rest of the sol to form an uniform slurry, which was then impregnated into the macroporous template PU sponge. Through such viscosity-controlled casting, a well distribution of the slurry onto PU struts was achieved (Fig. S1). After dried and calcinated, the mechanical stable TMS was finally obtained (detailed parameters are listed in Table 1). In this study, the specific viscosity of MBG sol was critical to the distribution of slurry on PU struts as well as the consequential interconnectivity, homogeneity and mechanical stability of the scaffold (Fig. S2). Within an optimal viscosity range (4.0 104– 6.0 104 mPa s), the shape of PU foam struts could be well reproduced by one-step casting and the scaffold exhibited an uniform and interconnected macroporous architecture. Moreover, by altering ratio of impregnated slurry amount and sponge volume, the scaffold porosity and macropore wall thickness could be easily modulated (Fig. S2). It could be observed from the micro-CT slice and SEM cross-section image that the MBG strut was dense and homogeneous, with a relatively small-sized (about 1/10 in diameter) space left by PU foam in the middle (Fig. S3). For better cell penetration and tissue ingrowth, the porosity of 80% was applied in the following in vitro and in vivo experiments.\nThe hierarchical porous structure of TMS was visualized through SRlCT scanning (Fig. S4), SEM and TEM (Fig. 2A). As shown in SRlCT images, the scaffold completely replicated the shape and macrostructure of PU sponge and exhibited excellent interconnectivity with a porosity above 80%. Uniformmacroporous morphology with interconnected pore size of 200–500 lm and a frame wall thickness of 50–80 lm was observed in SEM images (Fig. 2A, upper row). At a higher magnification (Fig. 2A, middle row), micro-sized pores (0.5–5 lm) were homogeneously distributed in the surface of macropore walls. TEM image illustrated the nanometric porosities within the macro-struts (Fig. 2A, bottom row). SAXRD patterns (Fig. 2B) showed three diffraction peaks (2h = 0.87 , 1.49 , 1.71 ), which could be indexed to the (110), (200), and (211) crystal planes of a 3D body centered cubic (Im3m) lattice. Brunauer–Emmett–Teller (BET) surface area and the average pore diameter of TMS were calculated to be 425.2 m2 g 1 and 7.5 nm respectively (Fig. 2C and Table 3). In contrast, both bimodal scaffolds exhibited a similar macroporous network, while there were no micropores in the macropore walls of BMSN, and BMS-M demonstrated a non-mesoporous texture. Detailed structural parameters were listed in Table 3.\nTo achieve ‘‘hard scaffold” with required strength for temporarily support in vivo, on the basis of the aforementioned ‘‘ viscosity-controlled” casting, we proposed a ‘‘homogeneous particle reinforcing” strategy by incorporating MBG particles with the\nsame composition and mesoporous structure into MBG sol (Fig. 2D). As the MBG particle content increased from 0% to 10%, the compressive strength of the scaffolds could be considerably improved from 0.64 MPa to 4.28 MPa, while a further increase of MBG particle proportion (20%) showed no significant enhancement of mechanical strength (Fig. 2E). In terms of the impregnative operability and the resulting mechanical strength, MBG particle content of 10% (italicized, Table 1) was considered as the optimal mass ratio for scaffold preparation and was applied in the following article. Even at a high porosity of 80%, the compressive strength of TMS can reached the range of human cancellous bone (2–12 MPa). Since macroporosity and macroporous size are the predominant factors of mechanical properties, the mechanical strength of bimodal porous scaffolds exhibited similar trends to TMS (Table 3). Nanostructure exerted little effect on mechanical strength, while microporosity slightly reduced the compressive strength of TMS and BMS-M."
    }, {
      "heading" : "3.2. RhBMP-2 delivery in mesopores",
      "text" : "RhBMP-2 delivery utilizing the mesoporous structure of MBG was explored in this study. To customize a nano-cavity entrapment of rhBMP-2, the adsorption and release behavior of rhBMP-2 in/ from mesopores supports with different diameters and structures were evaluated in preliminary experiments (Figs. S5 and S6). And\n(upper row) and surface topologies (middle row); TEM images of the nanostructures\nions. (D) Illustration of the enhancement of mechanical strength by the ‘‘viscosity\nof TMS with different MBG particle contents (scaffold porosity of 80%). The as-\nhigh interconnectivity, micropores (0.5–5 lm) uniformly embedded in macropore\nl viscosity and incorporating the MBG particles, a significantly enhanced mechanical\nences, p < 0.05.\nTable 3 Chemical compositions and structural parameters of TMS, BMS-N and BMS-M.\nSample name Chemical compositions (Molar ratio Si:Ca:P)\nHierarchical structure Interconnected Macropore size (lm) Micropore size (lm) Mesopore size (nm)\nBET surface area (m2 g 1) Mesopore volume (cm3 g 1)\nCompressive strength (MPa)\nTMS 85:10:5 Macro/ Micro/Nano 200–500 0.5–5.0 7.5 ± 0.2 425.2 0.631 4.28 ± 0.52 BMS-N 85:10:5 Macro/Nano 200–500 – 7.5 ± 0.2 411.5 0.617 4.46 ± 0.46 BMS-M 85:10:5 Macro/Micro 200–500 0.5–5.0 – 9.7 0.014 4.19 ± 0.56\naccordingly, MBG with 7.5 nm, Im3m mesoporous structure was adopted for its optimal loading and release behaviors. Intensively decreased peaks in SAXRD pattern (Fig. 3A) indirectly suggested the entry of rhBMP-2 into mesopores of TMS [34,36], which was reconfirmed by the release behavior in Fig. 3B. As shown in Fig. 3B, without mesoporous structure, BMS-M exhibited a burst release of rhBMP-2 within 24 h (33.7 lg, 67.4%) and 80.2% release in 3 d (40.1 lg), while a significantly prolonged release behavior could be achieved in TMS and BMS-N; in the release curve of TMS, an initial burst release of about 20.4% rhBMP-2 (10.2 lg) occurred on the first day, followed by a stable sustained release of another 59% (29.4 lg) during the next four weeks. By the end of the measurement period (28 d), there remained 20.6% residual rhBMP-2 (10.3 lg) in the scaffold. Furthermore, circular dichroism (CD) analysis revealed that the released rhBMP-2 remained its native structure (Fig. 3C and Table S2), and a comparable ALP activity was achieved by the TMS-released rhBMP-2 (Fig. 3D).\nFor further demonstration, osteogenic gene (Runx2, BSP, OPN and OCN) expressions, ALP and mineralization staining of rBMSCs on TMS, TMS/rhBMP-2, BMS-N/rhBMP-2 and BMS-M/rhBMP-2 were assessed (Fig. 3E and F). TMS itself exhibited very limited osteoinductivity, which was effectively enhanced after the incorporation of rhBMP-2. The mesoporous structure endowed TMS/ rhBMP-2 and BMS-N/rhBMP-2 with long-term delivery of rhBMP2. In contrast, BMS-M/rhBMP-2 without mesopores induced a comparable or slightly higher bone related gene expressions at the beginning (day 3), and a relatively lower expression at later stage (day 7 and 10) compared to TMS/rhBMP-2 and BMS-M/rhBMP-2 (Fig. 3E). As intuitively shown in ALP and mineralization staining, TMS/rhBMP-2 and BMS-N/rhBMP-2 induced higher ALP activity (Fig. 3F, upper row) and more mature mineralized nodules (Fig. 3F, bottom row) than BMS-M/rhBMP-2, owing to the sustained releasing behavior of rhBMP-2 from mesopores. It’s worth mentioning that TMS/rhBMP-2 group exhibited a higher ALP expression and\nm TMS. (A) SAXRD patterns of TMS and rhBMP-2 loaded TMS. (B) In vitro release\nlg). (C) Circular dichroism spectra of free rhBMP-2 and the rhBMP-2 released from\nTMS. (E) Bone-related gene expression of rBMSCs on different scaffolds at 3, 7 and\nmonstrated that a proper mesoporous structure was beneficial for rhBMP-2 loading,\n< 0.05.\nmineralization than the free rhBMP-2 with same amount, indicating that the mesopores served as a shelter for preserving activity of the protein, and thus solved the problem of short half-life of free rhBMP-2. A slightly enhanced ALP activity and mineralization of TMS/rhBMP-2 than BMS-N/rhBMP-2 hinted about the beneficial effects of microporous surface on rhBMP-2 induced osteogenesis."
    }, {
      "heading" : "3.3. In vitro cytocompatibility and bioactivity of scaffolds",
      "text" : "3D images of live/dead examination (Fig. 4A) suggested a deep penetration of rBMSCs into TMS, BMS-N and BMS-M with few apoptosis (red). As shown in Fig. 4B, approximately confluent rBMSCs had tightly anchored and spread on the macropore walls of both periphery and interior of the scaffolds. Such excellent cell attachment and penetration also occurred on HUVECs, an acknowledged cellular model for angiogenesis studies (Fig. S7). These results indicated that all trimodal and bimodal scaffolds showed excellent cytocompatibility and provided a desirable environment for cell attachment and ingrowth. For detailed cell morphology observation, SEM was conducted and well spread rBMSCs with significantly outstretched filopodia extensions was observed on the scaffold (Fig. 4C, left column). It’s worth noting that a leaf-like hydroxy-carbonate apatite crystal deposition, similar to the morphology of apatite in human bone [37,38], was extensively observed on the struts surface of TMS and BMS-M (Fig. 4C, right column), while such mineralization was not observed on BMS-N. As determined by EDS, carbonate peaks, as well as the content of calcium and phosphate relative to silica, indicate the formation of carbonated hydroxyapatite (HCA) and the degree of mineralization, which was higher in TMS and BMS-M than BMS-N. Protein adsorption (Fig. S8A), initial cell attachment (Fig. S8B) and ions release kinetics (Fig. S9) also exhibited a similar trend. These phenomena implied that the cell attachment and bioactivity of the scaffold was enhanced by the surface micropores, which might further benefit and accelerate the osteogenic process in vivo."
    }, {
      "heading" : "3.4. Ectopic bone formation of the rhBMP-2-loaded scaffolds",
      "text" : "The digital photographs and quantitative histograms (Fig. 5A and B) intuitively revealed the sizes and amounts of ectopic bone formation at week 2 and 4. All scaffolds successfully\ninduced ectopic bone formation in thigh muscle pouches of mice. The ectopic bone formation amounts (ash weight) of three groups showed no significant difference at week 2, and were TMS/rhBMP2 > BMS-N/rhBMP-2 > BMS-M/rhBMP-2 at week 4. As histological images shown in Fig. 5C, all three groups underwent a similar ectopic osteogenic process: a fibrous capsule wrapping a large number of lipocytes at week 2, followed by bone trabeculae formation at week 4. In TMS/rhBMP-2 implant, large amounts of bone trabeculae were uniformly distributed and extensive CD31 expression was observed around the newly formed bone. BMS-N/rhBMP-2 exhibited less formation of trabecular bone and CD31 expression, while BMS-M/rhBMP-2 showed discontinuous bone trabeculae and a large number of chondrocytes."
    }, {
      "heading" : "3.5. Orthotopic bone formation of the rhBMP-2 loaded scaffolds",
      "text" : ""
    }, {
      "heading" : "3.5.1. Micro-CT and X-ray",
      "text" : "As shown in the micro-CT and X-ray images (Figs. 6A and S10), extensive bone formation throughout the entire defect site was observed in all rhBMP-2 loaded groups, while TMS alone could not achieve satisfactory healing. The micro-CT images of week 4, 8 and 12 successively revealed a rapid bone bridging, basically recanalized medullary cavity and completed reunion of the defects in TMS/rhBMP-2. From the sectional views (Fig. S11), early woven bone had successfully transformed into compact bone and the recanalized medullary cavity exhibited a similar appearance to normal radius. In contrast, both bimodal groups exhibited relatively imperfect healing outcomes. BMS-N/rhBMP-2 group induced a comparable repair to TMS/rhBMP-2 due to its prolonged rhBMP-2 delivery, but a flawed medullary cavity still remained; BMS-M/ rhBMP-2 group appeared a rapid bone forming at the beginning, yet without a sustaining rhBMP-2 availability it failed in forming a completed medullary cavity. Quantitative orthotopic bone formation in ROI at week 12 was shown in Fig. 6B. Lowest quantity of regenerated bone in BMS-M/rhBMP-2 group reconfirmed that mesopores played an important role in desirable rhBMP-2 immobilization and sustained release, thus in turn exerted great effects on the in vivo bone reconstruction.\nIn this study, the regeneration process accompanied with gradual scaffold’s degradation could be intuitively observed from micro-CT and X-ray images. Taken TMS and TMS/rhBMP-2 as\n) Cell viability and penetration by live/dead assay (green: live cells, red: dead cells); alization, right column: 2D visualization, green: cytoskeleton, blue: cell nuclei). (C) r 12 h culture. All scaffolds exhibited excellent cytocompatibility and provided a y and hydroxyapatite depositions were observed in presence of micropores (on TMS er is referred to the web version of this article.)\nexample (Fig. S12), TMS alone exhibited a moderate degradation rate and about 75.4% degradation during the 12 weeks, while TMS/rhBMP-2 exhibited a higher degradation rate and a synchronizing complete degradation/regeneration at week 12."
    }, {
      "heading" : "3.5.2. Sequential fluorescent labeling",
      "text" : "Sequential fluorescent labeling was used to analyze the bone formation and remodeling at different time intervals in vivo. As shown in Fig. 7, at early stage post-implantation (2–4 weeks), all three groups exhibited a rapid bone formation, and TMS/rhBMP2 group showed a larger labeling area and slightly higher new bone formation rate than the bimodal groups. During week 6–8, the rate of bone mineralization in TMS/rhBMP-2 group was slowed down since it has basically recanalized the medullary cavity and stepped into the stage of bone remodeling; while BMS-N/rhBMP-2 group still had great growth potential and exhibited the highest bone\nformation rate to bridge the marrow cavity; BMS-M/rhBMP-2 group however, showed a lowest bone formation rate because of insufficient rhBMP-2 retention. At week 10, a completely recanalized medullary cavity was only achieved in TMS/rhBMP-2; BMSN/rhBMP-2 exhibited an incomplete one, while BMS-M/rhBMP-2 revealed a non-healing outcome."
    }, {
      "heading" : "3.5.3. Histological analyses",
      "text" : "Masson’s trichrome staining (Fig. 8) together with HE staining (Fig. S13) revealed a typical endochondral bone formation process [39,40]. In TMS/rhBMP-2 group, the defect site was filled by plenty of chondrocytes and newly formed cartilage at week 2, which gradually transformed into woven bone at week 4, followed by further mineralization into lamellar bone and formation of the medullary cavity. At week 12, maturely mineralized lamellar bone with typical ring-like Haversian osteons and blood vessels, as well as a\nmatured bone marrow cavity with medulla ossium flava and medulla ossium rubra was achieved in TMS/rhBMP-2. In contrast, a similar regeneration process was observed in the group BMS-N/ rhBMP-2, yet less integrity and maturity of the healed bone was exhibited at week 12. In the case of BMS-M/rhBMP-2, obviously unhealed area still existed, and it failed in forming a recanalized medullary cavity at week 12. Such accelerated bone reconstruction reconfirmed the excellent regenerative effects of TMS/rhBMP-2.\nVan Gieson’s picro fuchsin staining also exhibited a similar tendency (Fig. 9). At week 4, extensive mineralization and massive woven bone were observed in all groups. Numerous osteocytes were embedded in the bone matrix, and osteoblasts lined around the newly formed bone. At week 4, TMS/rhBMP-2 and BMS-M/ rhBMP-2 exhibited a similar regenerative situation, while a thinner woven bone network was observed in BMS-N/rhBMP-2. At week 8, woven bone was gradually remodeled into lamellar bone and recanalized medullary cavity was formed. Basically recanalized bone marrow and lamellar bone with new vessels were observed in TMS/rhBMP-2 and BMS-N/rhBMP-2, while BMS-M/rhBMP-2 remained massive irregular woven bones and obviously unhealed areas."
    }, {
      "heading" : "4. Discussion",
      "text" : "Because of the existing deficiencies in current treatments for critical size defects, ideal bone substitutes are in urgent need of development. Herein, TMS/rhBMP-2 with osteoconductive trimodal macro/micro/nano-porous structure and osteoinductive rhBMP-2 delivery was successfully designed and fabricated to achieve complete bone regeneration in critical size defects.\nCurrently, there are mainly two methods for preparing 3D ordered MBG scaffolds with highly interconnected macropores: PU foam replication [41–43], and 3D printing technique [9,44]. Although 3D printing represents an accurate and precise method for the fabrication of porous scaffolds, inherent non-printable character of MBG makes it require a printable base material (such as PVA and PCL) for molding, which has greatly compromised the unique mesoporous structure and biological properties of MBG. Comparatively, PU template method is a more accessible strategy to make the most of the excellent properties of MBG. However, in a traditional PU template process, low viscosities of MBG sol allows very little coating amount of MBG on PU struts, which leads to a thin and fragile MBG matrix after calcination; and then the\nrepeated casting–squeezing–drying process results in discontinuity of each coating layer [45,46]. It’s worth noting that, as an inherent property of scaffolds prepared by PU templating method, the space left by PU foam could not be avoided. In this case, the space left behind PU aggravates such mechanical fragility of the heterogeneous and non-continuous MBG macrostructure. Till now, this problem remains a mechanical bottleneck of scaffolds produced by PU template methods, and makes it too weak to handle in further animal experiments and clinical application.\nTo solve these problems, we proposed a ‘‘viscosity controlling” and ‘‘homogeneous particle reinforcing” strategy for controllable preparation and mechanical enhancement. First of all, structure stability is the assurance of desirable mechanical properties. To improve the mechanical properties of MBG scaffolds, the prerequisite is to ensure the integrity and uniformity of the macroporous network. In our improved ‘‘viscosity-controlled one-step casting” process, with an increased viscosity by a rotary evaporated process, the viscous MBG sol has a desirable adhesive capability that allows to form an uniform network as well as thick and dense macropore wall. This method endows MBG scaffold with homogeneous, continuous and stable macro-structure, abates the mechanical weakness of PU space to a greatest extent, and thus lays a foundation for further improvement of the mechanical strength (Figs. S2 and S3).\nIn order to meet the mechanical requirements of surgical procedures and clinical applications, we further proposed a ‘‘homogeneous particle-reinforcing” strategy on the basis of the above-mentioned ‘‘viscosity-controlled casting” process. As an extension of traditional ‘‘particle reinforcement” definition, such self-reinforcing by incorporating particle and sol of the same composition exhibited an effective enhancement effect. Based on\nprevious reports and our results, the significantly enhanced compressive strength could be attributed to two possible reasons. One is the typical load transfer effect in particle reinforcing system [47,48]. Under an applied load, the load is transferred from the matrix, across the matrix/particle interface, to the reinforcement phase. In this manner, strengthening takes place by the reinforcement ‘‘carrying” part of the applied load and efficiently absorbs and dissipates impact energy. The other reason is related to the compatible interface between reinforcement and matrix. It’s well recognized that debonding and cracking along the reinforcement/ matrix interface is one of the common fracture processes that occur in particle reinforcing systems [49], which could be avoided in the ‘‘homogeneous particle-reinforcing” system of MBG scaffold. In previous work, Hench proved that heating silica gel above 400 C could lead to the condensation of surface hydroxyl groups and formation a Si–O–Si network [50]. In present study, MBG particles have the same mesoporous structure and chemical composition as MBG matrix, during the calcination process their could form a stable Si–O–Si network at the interface, thus avoid the incompatible interface problem. Moreover, the matching degradation rate between particle and matrix also could avoid cytotoxicity caused by particle migration in traditional particle-reinforcing systems. Through this facile strategy, the TMS reproduced the interior macroporous network of PU foam and exhibited an improved mechanical strength comparable to cancellous bone. By controlling the addition of microporous and mesoporous templates, scaffolds with desirable trimodal macro/micro/nano-porosities could be produced.\nBased on the successful preparation of mechanical stable trimodal porous scaffold, we for the first time systematically investigated the osteogenic performances of rhBMP-2 loaded trimodal\nporous scaffold in vivo. This bioinspired system induced complete regeneration of critical size defect with rapid medullary cavity reunion and sclerotin maturity. The underlying mechanism of the\nexcellent therapeutic efficacy of TMS/rhBMP-2 remains an open question, to which we might provide some ideas by combining existing related theories with our results (Fig. 10).\nAccording to the existing theories of endochondral bone formation [39,51], the regeneration process in this study could be divided into three stages: inflammation and cartilage formation (0–2 weeks), primary bone formation (2–4 weeks), and bone remodeling (after 4 weeks). Since over 90% of the scaffold degraded by week 8 (Fig. S12), we believe that the osteogenic promotion of TMS/rhBMP-2 mainly occurred in the first 8 weeks after implantation, then the following tissue maturity after 8 weeks mainly depended on self-remodeling of the newly formed bone tissue. As the acting time of TMS/rhBMP-2 covered the above stages of endochondral bone formation, the healing performances of TMS/ rhBMP-2 in each stage will be discussed accordingly.\nInitial stage (0–2 weeks): inflammation and cartilage formation. After fracture takes place, inflammatory cells secrete cytokines and growth factors at the traumatic hematoma site, which modulate the recruitment of MSCs; then MSCs differentiate into chondrocytes and form cartilage at the defect site. As shown in histological analyses (Figs. 8 and S13), massive chondrocytes, extensive cartilage tissue and local woven bone formation were observed in TMS/rhBMP-2; while in BMS-N/rhBMP-2 group, large numbers of chondrocytes have not yet formed obvious cartilage tissue; and BMS-M/rhBMP-2 exhibited a similar but slightly inferior situation to TMS/rhBMP-2.\nGiven that BMP-2 was reported to induce chemotaxis and chondrogenesis of MSCs at this stage [27,52], we first considered whether the difference came from different rhBMP-2 concentrations. The rhBMP-2 concentration at the defect site could be predicted according to the in vitro releasing curves (Fig. 3B): at the initial stage, TMS/rhBMP-2 and BMS-N/rhBMP-2 exhibited a similar release percentage of 60% (32.7 lg and 29.2 lg respectively), while BMS-M/rhBMP-2 showed a burst release of 90% (44.6 lg). This tendency was inconsistent with the regenerative outcome, which indicated that although rhBMP-2 played an important role in MSCs recruitment and differentiation, the discrepancy was not caused by different rhBMP-2 concentrations. However, without sustained release based on mesopores, the burst release of BMSM/rhBMP-2 not only deduced the utilization of the protein, but also brought carcinogenic and complication risks associated with excessive concentrations of rhBMP-2 [53,54].\nMicropores might be the predominant promotion at this stage. In this study, we define this promotion by micropores at the early stage of regeneration as an ‘‘initial micropore-acceleration”. Combining previous literatures with our results, we speculated several\npossible reasons for this acceleration as follows. By providing a larger surface area, the microporosities could facilitate the coprecipitation of endogenous cytokines and growth factor, which indirectly stimulate stem cells recruitment to the defect site [21,55]. After then, surfaces with microporous topologies could significantly enhance biomineralization (Fig. 4C) and were beneficial for protein adsorption and cell attachment (Fig. S8). During cartilage formation, newly formed collagen fibers mineralized and wrapped in the micropores forming tight interlock between material and tissue, resulting in a bone/scaffold composite with no ‘‘dead space” [22,56]. Due to this ‘‘initial micropore-acceleration”, the healing progress of TMS/rhBMP-2 and BMS-M/rhBMP-2 were in ahead of BMS-N/rhBMP-2.\nPrimary bone formation stage (2–4 weeks): angiogenesis and osteogenesis. At this stage, the cartilage tissues are vascularized, surrounded by osteoblasts and progressively replaced by woven bone. As shown in Masson’s staining (Fig. 8), the initial cartilage has turned into woven bone. Among three groups, a higher amount and rate of bone formation could be observed in TMS/rhBMP-2 during 2–4 weeks (Fig. 7). While, BMS-N/rhBMP-2 and BMS-M/ rhBMP-2 exhibited a lagging and slow-down regenerative progress, respectively. Vascularization is the prerequisite of nutrition transportation for ossification at this stage [57,58]. Apart from its well-accepted osteoinductive capacity, rhBMP-2 was also reported to promote angiogenesis through stimulating the endogenous expression of VEGF [59,60]. In accordance with the ectopic results (Fig. 5), we believe that the emerging gap between TMS/rhBMP-2 and BMS-M/rhBMP-2 comes from the different release behavior of rhBMP-2. Without sustained release of rhBMP-2 based on mesopores, 90% rhBMP-2 was released from BMS-M/rhBMP-2 at the first stage, and the residual could not maintain its optimal angiogenic and osteoinductive capacity at later stages. Due to the lack of the ‘‘initial micropore-acceleration” at first stage, the regenerative progress of BMS-N/rhBMP-2 at week 4 was non-equivalent to TMS/rhBMP-2.\nBone remodeling stage (after 4 weeks): medullary cavity reunion and bone maturity. After the defect site was fully vascularized and filled with woven bone, the irregular woven bone was remodeled, by the cooperation of osteoclastic bone resorption and osteoblastic bone formation, to adjust its architecture to form matured lamellar bone and medullary cavity. As shown in the results (Figs. 6–8), in TMS/rhBMP-2 group, lamellar bone with haversian osteons and an integrated recanalized medullary cavity\nlete regeneration in segmental critical size defect. Different colors correspond to the o color in this figure legend, the reader is referred to the web version of this article.)\nwas formed at week 8; a complete regenerative outcome was achieved at week 12. In contrast, BMS-N/rhBMP-2 and BMS-M/ rhBMP-2 exhibited an incomplete and non-healing regeneration, respectively. The bone remodeling stage is mainly based on the completion status of the above two stages. As TMS/rhBMP-2 achieved an optimal regenerative performance without ‘‘dead space” in the first two stages, the matured osteoblasts and residual rhBMP-2 at the defect site could promote osteoclastogenesis as reported [28,61], thus further accelerated the remodeling process. While the two bimodal groups reached flawed regenerative outcomes, which required more time to improve during remodeling.\nThroughout this whole process, interconnected macropores, as the basic structural support for bone regeneration, could ensure nutrition transportation, promote vascularization, and provide space for ingrowth of new vessels and bone tissue [10,62]. And BMP-2, as the key factor that is expressed throughout the bone regeneration process, serves various functions at different stages [39,51]. Therefore, its sustained release over a long period becomes the key of design for complete regeneration. Above all, the superior in vivo performances of TMS/rhBMP-2 could be ascribed to the trimodal porous structure and osteogenic growth factor, as well as the ideal design that put these physicochemical and biological cues together so that they complement each other in each stage of the healing process."
    }, {
      "heading" : "5. Conclusion",
      "text" : "A robust biomimetic MBG scaffold with trimodal macro/micro/ nano-porous structure and efficient rhBMP-2 immobilization for accelerated bone regeneration was constructed in this study. An efficient ‘‘viscosity-controlled” casting process, together with ‘‘homogeneous particle reinforcing” strategy successfully improved the structural stability and mechanical strength of the scaffold, extending the utility of MBG scaffolds to the treatment of segmental load-bearing defects. The concept of a ‘‘customized nano-cavity entrapment” of rhBMP-2 solved the common problems in growth factor delivery: protein denaturation, low loading and unsatisfactory release kinetics. And for the first time, we investigated the bone regeneration capacity of osteogenic growth factor-loaded trimodal porous scaffold in vitro and in vivo. On the basis of systematical studies, the as-prepared TMS/rhBMP-2 exhibited inspiring properties in terms of osteoconductivity, osteoinductivity, rhBMP-2 delivery and biodegradability. We believe that this work can pave the way for wider uses of trimodal porous scaffold in clinical application and arouse broad interests among researchers in the fields of bone tissue engineering, hierarchical porous scaffolds and mesoporous materials."
    }, {
      "heading" : "Acknowledgments",
      "text" : "The authors would like to express their gratitude to the financial supports from National Basic Research Program of China (973 Program, No. 2012CB933600), the 111 Project (B14018), National Natural Science Foundation of China (Nos. 31330028 and 31470924) and New Century Excellent Talents in University (No. NCET-11-0640)."
    }, {
      "heading" : "Appendix A. Supplementary material",
      "text" : "Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.actbio.2015.12. 006."
    } ],
    "references" : [ {
      "title" : "Induced periosteum a complex cellular scaffold for the treatment of large bone defects",
      "author" : [ "R.J. Cuthbert", "S.M. Churchman", "H.B. Tan", "D. Mcgonagle", "E. Jones", "P.V. Giannoudis" ],
      "venue" : "Bone 57 ",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "H. Yuan", "H. Fernandes", "P. Habibovic" ],
      "venue" : "de Boer, A.M.C. Barradas, A. de Ruiter, et al., Osteoinductive ceramics as a synthetic alternative to autologous bone grafting, Proc. Natl. Acad. Sci. USA 107 ",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "The use of a novel bone allograft wash process to generate a biocompatible",
      "author" : [ "C.A. Smith", "S.M. Richardson", "M.J. Eagle", "P. Rooney", "T. Board", "J.A. Hoyland" ],
      "venue" : "mechanically stable and osteoinductive biological scaffold for use in bone tissue engineering, J. Tissue Eng. Regen. Med. 9 ",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "L",
      "author" : [ "I. Dumic-Cule", "M. Pecina", "M. Jelic", "M. Jankolija", "I. Popek" ],
      "venue" : "Grgurevic, et al., Biological aspects of segmental bone defects management, Int. Orthop. 39 ",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "C",
      "author" : [ "A.M. Collins", "N.J.V. Skaer", "T. Gheysens", "D. Knight" ],
      "venue" : "Bertram, H.I. Roach, et al., Bone-like resorbable silk-based scaffolds for load-bearing osteoregenerative applications, Adv. Mater. 21 ",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Elastomeric and mechanically stiff nanocomposites from poly(glycerol sebacate) and bioactive nanosilicates",
      "author" : [ "P. Kerativitayanan", "A.K. Gaharwar" ],
      "venue" : "Acta Biomater. 26 ",
      "citeRegEx" : "6",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Biphasic peptide amphiphile nanomatrix embedded with hydroxyapatite nanoparticles for stimulated osteoinductive response",
      "author" : [ "J.M. Anderson", "J.L. Patterson", "J.B. Vines", "A. Javed", "S.R. Gilbert", "H.W. Jun" ],
      "venue" : "ACS Nano 5 ",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Bioceramics: from bone regeneration to cancer nanomedicine",
      "author" : [ "M. Vallet-Regí", "E. Ruiz-Hernández" ],
      "venue" : "Adv. Mater. 23 ",
      "citeRegEx" : "8",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "C",
      "author" : [ "J. Zhang", "S. Zhao", "Y. Zhu", "Y. Huang", "M. Zhu" ],
      "venue" : "Tao, et al., Three-dimensional printing of strontium-containing mesoporous bioactive glass scaffolds for bone regeneration, Acta Biomater. 10 ",
      "citeRegEx" : "9",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Porous scaffold design for tissue engineering",
      "author" : [ "S.J. Hollister" ],
      "venue" : "Nature Mater. 4 ",
      "citeRegEx" : "10",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "P",
      "author" : [ "J. Kim", "S. McBride", "B. Tellis" ],
      "venue" : "Alvarez-Urena, Y.-H. Song, D.D. Dean, et al., Rapid-prototyped PLGA/b-TCP/hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model, Biofabrication 4 ",
      "citeRegEx" : "11",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Tyrosinederived polycarbonate scaffolds for bone regeneration in a rabbit radius critical-size defect model",
      "author" : [ "J. Kim", "S. McBride", "A. Donovan", "A. Darr", "M.H.R. Magno", "J.O. Hollinger" ],
      "venue" : "Biomed. Mater. 10 ",
      "citeRegEx" : "12",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "P",
      "author" : [ "J. Kim", "M.H.R. Magno", "H. Waters", "B.A. Doll", "S. McBride" ],
      "venue" : "Alvarez, et al., Bone regeneration in a rabbit critical-sized calvarial model using tyrosine-derived polycarbonate scaffolds, Tissue Eng. Part A 18 ",
      "citeRegEx" : "13",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Macroscale delivery systems for molecular and cellular payloads",
      "author" : [ "C.J. Kearney", "D.J. Mooney" ],
      "venue" : "Nature Mater. 12 ",
      "citeRegEx" : "14",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Bioinspired fabrication of 3D hierarchical porous nanomicrostructures calcium carbonate for bone regeneration",
      "author" : [ "H. Yu", "Z. Zhang", "Y. Win", "J. Chan", "H. Teoh", "M. Han" ],
      "venue" : "Chem. Commun. 46 ",
      "citeRegEx" : "15",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Review of bioactive glass: from Hench to hybrids",
      "author" : [ "J.R. Jones" ],
      "venue" : "Acta Biomater. 9 ",
      "citeRegEx" : "16",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "J",
      "author" : [ "S.A. Yavari" ],
      "venue" : "van der Stok, Y.C. Chai, R. Wauthle, Z.T. Birgani, P. Habibovic, et al., Bone regeneration performance of surface-treated porous titanium, Biomaterials 35 ",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Enhanced osseointegration of titanium implants with nanostructured surfaces: an experimental study in rabbits",
      "author" : [ "L. Salou", "A. Hoornaert", "G. Louarn", "P. Layrolle" ],
      "venue" : "Acta Biomater. 11 ",
      "citeRegEx" : "18",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Q",
      "author" : [ "B. Tian", "J. Liu", "T. Dvir", "L. Jin", "J.H. Tsui" ],
      "venue" : "Qing, et al., Macroporous nanowire nanoelectronic scaffolds for synthetic tissues, Nature Mater. 11 ",
      "citeRegEx" : "19",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Three-dimensional biomaterials for the study of human pluripotent stem cells",
      "author" : [ "T.P. Kraehenbuehl", "R. Langer", "L.S. Ferreira" ],
      "venue" : "Nature Methods 8 ",
      "citeRegEx" : "20",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Porosity of 3D biomaterial scaffolds and osteogenesis",
      "author" : [ "V. Karageorgiou", "D. Kaplan" ],
      "venue" : "Biomaterials 26 ",
      "citeRegEx" : "21",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Biomaterials topographic scalerange synergy at the functional bone/implant interface",
      "author" : [ "J.E. Davies", "V.C. Mendes", "J.C.H. Ko", "E. Ajami" ],
      "venue" : "Biomaterials 35 ",
      "citeRegEx" : "22",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Designing materials to direct stem-cell fate",
      "author" : [ "M.P. Lutolf", "P.M. Gilbert", "H.M. Blau" ],
      "venue" : "Nature 462 ",
      "citeRegEx" : "23",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Hierarchical porous materials for tissue engineering",
      "author" : [ "J.R. Jones", "P.D. Lee", "L.L. Hench" ],
      "venue" : "Philos. Trans. A Math. Phys. Eng. Sci. 364 ",
      "citeRegEx" : "24",
      "shortCiteRegEx" : null,
      "year" : 2006
    }, {
      "title" : "Sol-gel silica-based biomaterials and bone tissue regeneration",
      "author" : [ "D. Arcos", "M. Vallet-Regí" ],
      "venue" : "Acta Biomater. 6 ",
      "citeRegEx" : "25",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Design and preparation of bioactive glasses with hierarchical pore networks",
      "author" : [ "H. Yun", "S. Kim", "Y. Hyeon" ],
      "venue" : "Chem. Commun. 21 ",
      "citeRegEx" : "26",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "A",
      "author" : [ "S. Facca", "C. Cortez", "C. Mendoza-Palomares", "N. Messadeq" ],
      "venue" : "Dierich, A.P.R. Johnston, et al., Active multilayered capsules for in vivo bone formation, Proc. Natl. Acad. Sci. USA 107 ",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Bone remodeling during fracture repair: The cellular picture",
      "author" : [ "A. Schindeler", "M.M. Mcdonald", "P. Bokko", "D.G. Little" ],
      "venue" : "Semin. Cell Dev. Biol. 19 ",
      "citeRegEx" : "28",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Osseointegration: the slow delivery of BMP-2 enhances osteoinductivity",
      "author" : [ "E.B. Hunziker", "L. Enggist", "A. Küffer", "D. Buser", "Y. Liu" ],
      "venue" : "Bone 51 ",
      "citeRegEx" : "29",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect",
      "author" : [ "L. Li", "G. Zhou", "Y. Wang", "G. Yang", "S. Ding", "S. Zhou" ],
      "venue" : "Biomaterials 37 ",
      "citeRegEx" : "30",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Chemical strategies for generating protein biochips",
      "author" : [ "P. Jonkheijm", "D. Weinrich", "H. Schröder", "C.M. Niemeyer", "H. Waldmann" ],
      "venue" : "Angew. Chem. Int. Ed. 47 (2008) 9618–9647.  W. Tang et al. / Acta Biomaterialia 32 ",
      "citeRegEx" : "31",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Localized delivery of growth factors for bone repair",
      "author" : [ "V. Luginbuehl", "L. Meinel", "H.P. Merkle", "B. Gander" ],
      "venue" : "Eur. J. Pharm. Biopharm. 58 ",
      "citeRegEx" : "32",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Mineral coatings for temporally controlled delivery of multiple proteins",
      "author" : [ "J.S. Lee", "D. Suarez-gonzalez", "W.L. Murphy" ],
      "venue" : "Adv. Mater. 23 ",
      "citeRegEx" : "33",
      "shortCiteRegEx" : null,
      "year" : 2011
    }, {
      "title" : "Proteins in mesoporous silicates",
      "author" : [ "S. Hudson", "J. Cooney", "E. Magner" ],
      "venue" : "Angew. Chem. Int. Ed. 47 ",
      "citeRegEx" : "34",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Ordered mesoporous materials for bioadsorption and biocatalysis",
      "author" : [ "M. Hartmann" ],
      "venue" : "Chem. Mater. 17 ",
      "citeRegEx" : "35",
      "shortCiteRegEx" : null,
      "year" : 2005
    }, {
      "title" : "Adsorption of cytochrome c on mesoporous molecular sieves: Influence of pH",
      "author" : [ "A. Vinu", "V. Murugesan", "O. Tangermann", "M. Hartmann" ],
      "venue" : "pore diameter, and aluminum incorporation, Chem. Mater. 16 ",
      "citeRegEx" : "36",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers",
      "author" : [ "Y. Hong", "X. Chen", "X. Jing", "H. Fan", "Z. Gu", "X. Zhang" ],
      "venue" : "Adv. Funct. Mater. 20 ",
      "citeRegEx" : "37",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "Bone repair: new developments in growth factor delivery systems and their mathematical modeling",
      "author" : [ "M. Lauzon", "É. Bergeron", "B. Marcos", "N. Faucheux" ],
      "venue" : "J. Control Release 162 ",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "Angiogenesis and bone repair",
      "author" : [ "D.T. Vo" ],
      "venue" : "Drug Discov. Today 6446 ",
      "citeRegEx" : "40",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "W",
      "author" : [ "D. Desimone" ],
      "venue" : "Li, J.a. Roether, D.W. Schubert, M.C. Crovace, A.C.M. Rodrigues, et al., Biosilicate – gelatine bone scaffolds by the foam replica technique: development and characterization, Sci. Technol. Adv. Mater. 14 ",
      "citeRegEx" : "41",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Characterisation of Bioglass based foams developed via replication of natural marine sponges",
      "author" : [ "E. Boccardi", "A. Philippart", "J.A. Juhasz-Bortuzzo", "G. Novajra", "C. Vitale-Brovarone", "A.R. Boccaccini" ],
      "venue" : "Adv. Appl. Ceram. 114 ",
      "citeRegEx" : "42",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Preparation and characterization of vancomycin releasing PHBV coated 45S5 Bioglass -based glass–ceramic scaffolds for bone tissue engineering",
      "author" : [ "W. Li", "P. Nooeaid", "J.A. Roether", "D.W. Schubert", "A.R. Boccaccini" ],
      "venue" : "J. Eur. Ceram. Soc. 34 ",
      "citeRegEx" : "43",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Three-dimensional mesoporous– giantporous inorganic/organic composite scaffolds for tissue engineering",
      "author" : [ "H. Yun", "S. Kim", "Y. Hyun", "S. Heo", "J. Shin" ],
      "venue" : "Chem. Mater. 19 ",
      "citeRegEx" : "44",
      "shortCiteRegEx" : null,
      "year" : 2007
    }, {
      "title" : "Structure–property relationships of silk-modified mesoporous bioglass scaffolds",
      "author" : [ "C. Wu", "Y. Zhang", "Y. Zhu", "T. Friis", "Y. Xiao" ],
      "venue" : "Biomaterials 31 ",
      "citeRegEx" : "45",
      "shortCiteRegEx" : null,
      "year" : 2010
    }, {
      "title" : "J",
      "author" : [ "C. Wu", "Y. Zhou", "M. Xu", "P. Han", "L. Chen" ],
      "venue" : "Chang, et al., Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity, Biomaterials 34 ",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "In vitro and in vivo behavior of self-reinforced bioabsorbable polymer and self-reinforced  bioabsorbable polymer/bioactive glass composites",
      "author" : [ "H. Niiranen", "T. Pyhältö", "P. Rokkanen", "M. Kellomäki", "P. Törmälä" ],
      "venue" : "J. Biomed. Mater. Res. A 69 ",
      "citeRegEx" : "47",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "Effects of particle size",
      "author" : [ "S.Y. Fu", "X.Q. Feng", "B. Lauke", "Y.W. Mai" ],
      "venue" : "particle/matrix interface adhesion and particle loading on mechanical properties of particulate-polymer composites, Compos. Part B Eng. 39 ",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "Fracture of aluminium reinforced with densely packed ceramic particles: link between the local and the total work of fracture",
      "author" : [ "A. Miserez" ],
      "venue" : "Acta Mater. 52 ",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2004
    }, {
      "title" : "The sol–gel process",
      "author" : [ "L.L. Hench", "J.K. West" ],
      "venue" : "Chem. Rev. 90 ",
      "citeRegEx" : "50",
      "shortCiteRegEx" : null,
      "year" : 1990
    }, {
      "title" : "Mechanisms of bone repair and regeneration",
      "author" : [ "F. Deschaseaux", "L. Sensébé", "D. Heymann" ],
      "venue" : "Trends Mol. Med. 15 ",
      "citeRegEx" : "51",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing",
      "author" : [ "J.K. Gaston", "J.H. Francis" ],
      "venue" : "J. Clin. Periodontol. 28 ",
      "citeRegEx" : "52",
      "shortCiteRegEx" : null,
      "year" : 2001
    }, {
      "title" : "Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings",
      "author" : [ "N.J. Shah", "N. Hyder", "J.S. Moskowitz", "M.A. Quadir", "M. Spector", "P.T. Hammond" ],
      "venue" : "Sci. Transl. Med. 5 ",
      "citeRegEx" : "53",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "The effect of dose on rhBMP-2 signaling",
      "author" : [ "R. Youn", "J. Hye", "B. Seok", "Y. Seo", "S. Jung", "I. Sook" ],
      "venue" : "delivered via collagen sponge, on osteoclast activation and in vivo bone resorption, Biomaterials 35 ",
      "citeRegEx" : "54",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "The effect of BMP-2 on micro- and macroscale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity",
      "author" : [ "S.K. Lan", "S.J. Polak", "M.J. Poellmann", "D.J. Hoelzle", "A.J. Maki", "S.G. Clark" ],
      "venue" : "Acta Biomater",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2010
    }, {
      "title" : "C",
      "author" : [ "W. Zhang", "G. Wang", "Y. Liu", "X. Zhao", "D. Zou" ],
      "venue" : "Zhu, et al., The synergistic effect of hierarchical micro/nano-topography and bioactive ions for enhanced osseointegration, Biomaterials 34 ",
      "citeRegEx" : "56",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "Angiogenesis in health and disease",
      "author" : [ "P. Carmeliet" ],
      "venue" : "Nature Med. 9 ",
      "citeRegEx" : "57",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix",
      "author" : [ "J. Li", "Y.P. Zhang", "R.S. Kirsner" ],
      "venue" : "Microsc. Res. Tech. 60 ",
      "citeRegEx" : "58",
      "shortCiteRegEx" : null,
      "year" : 2003
    }, {
      "title" : "H",
      "author" : [ "M.L.D. Martine", "L.V.B. Rutger", "V.D.H. Geertje" ],
      "venue" : "Jakomijn, V.D.B. Chris, E.P. Socrates, et al., Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A, Endocrinology 143 ",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2002
    }, {
      "title" : "Osteogenesis and angiogenesis: the potential for engineering bone",
      "author" : [ "J.M. Kanczler", "R.O. Oreffo" ],
      "venue" : "Eur. Cells Mater. 15 ",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2008
    }, {
      "title" : "a",
      "author" : [ "H. Kaneko", "T. Arakawa", "H. Mano", "T. Kaneda" ],
      "venue" : "Ogasawara, M. Nakagawa, et al., Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts, Bone 27 ",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2000
    }, {
      "title" : "S",
      "author" : [ "S. Ryu", "C. Lee", "J. Park", "J.S. Lee" ],
      "venue" : "Kang, Y.D. Seo, et al., Three-dimensional scaffolds of carbonized polyacrylonitrile for bone tissue regeneration, Angew. Chem. Int. Ed. 53 ",
      "citeRegEx" : "62",
      "shortCiteRegEx" : null,
      "year" : 2014
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Critical size bone defects resulting from nonunion fractures, severe trauma, congenital deficiency, malignancy resection or clinical challenges worldwide [1,2].",
      "startOffset" : 154,
      "endOffset" : 159
    }, {
      "referenceID" : 1,
      "context" : "Critical size bone defects resulting from nonunion fractures, severe trauma, congenital deficiency, malignancy resection or clinical challenges worldwide [1,2].",
      "startOffset" : 154,
      "endOffset" : 159
    }, {
      "referenceID" : 2,
      "context" : "Autograft remains the gold standard in orthopedic surgery due to its excellent osteoinductive and osteoconductive capability, yet limited tissue availability, donor site morbidity and additional surgical pain restrict their clinical applications [3,4].",
      "startOffset" : 246,
      "endOffset" : 251
    }, {
      "referenceID" : 3,
      "context" : "Autograft remains the gold standard in orthopedic surgery due to its excellent osteoinductive and osteoconductive capability, yet limited tissue availability, donor site morbidity and additional surgical pain restrict their clinical applications [3,4].",
      "startOffset" : 246,
      "endOffset" : 251
    }, {
      "referenceID" : 6,
      "context" : "Unfortunately, current available bone substitutes often exhibit either poor ‘‘osteoconductivity” or limited ‘‘osteoinductivity”, resulting in undesirable therapeutic efficacy [7,8].",
      "startOffset" : 175,
      "endOffset" : 180
    }, {
      "referenceID" : 7,
      "context" : "Unfortunately, current available bone substitutes often exhibit either poor ‘‘osteoconductivity” or limited ‘‘osteoinductivity”, resulting in undesirable therapeutic efficacy [7,8].",
      "startOffset" : 175,
      "endOffset" : 180
    }, {
      "referenceID" : 8,
      "context" : "Inspired by the impressive property of natural bone, three-dimensional hierarchical porous scaffolds, which can provide transportation ‘‘highways” on various scales during osteo-regeneration, and promote the innate regenerative mechanisms of the human body, have attracted significant attention [9,10].",
      "startOffset" : 295,
      "endOffset" : 301
    }, {
      "referenceID" : 9,
      "context" : "Inspired by the impressive property of natural bone, three-dimensional hierarchical porous scaffolds, which can provide transportation ‘‘highways” on various scales during osteo-regeneration, and promote the innate regenerative mechanisms of the human body, have attracted significant attention [9,10].",
      "startOffset" : 295,
      "endOffset" : 301
    }, {
      "referenceID" : 16,
      "context" : "glass) [14–16] and metals (stainless steel, titanium) [17,18], etc.",
      "startOffset" : 54,
      "endOffset" : 61
    }, {
      "referenceID" : 17,
      "context" : "glass) [14–16] and metals (stainless steel, titanium) [17,18], etc.",
      "startOffset" : 54,
      "endOffset" : 61
    }, {
      "referenceID" : 18,
      "context" : "Numerous studied have concluded that interconnected macroporosity with diameter larger than 100 lm is a prerequisite for bone ingrowth, cellular infiltration and nutrient/waste transportation [19,20]; and micro- and nano-topologies on the material surface play a critical role on cell attachment, biomineralization and fullscale osteointegration in vivo [21–23].",
      "startOffset" : 192,
      "endOffset" : 199
    }, {
      "referenceID" : 19,
      "context" : "Numerous studied have concluded that interconnected macroporosity with diameter larger than 100 lm is a prerequisite for bone ingrowth, cellular infiltration and nutrient/waste transportation [19,20]; and micro- and nano-topologies on the material surface play a critical role on cell attachment, biomineralization and fullscale osteointegration in vivo [21–23].",
      "startOffset" : 192,
      "endOffset" : 199
    }, {
      "referenceID" : 23,
      "context" : "However, the current reports were mainly focused on bimodal macro/nano- and micro/nano-scaffold [24,25], only one literature to date has reported a trimodal macro/micro/nanoporous scaffold for bone tissue engineering based on MBG [26].",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 24,
      "context" : "However, the current reports were mainly focused on bimodal macro/nano- and micro/nano-scaffold [24,25], only one literature to date has reported a trimodal macro/micro/nanoporous scaffold for bone tissue engineering based on MBG [26].",
      "startOffset" : 96,
      "endOffset" : 103
    }, {
      "referenceID" : 25,
      "context" : "However, the current reports were mainly focused on bimodal macro/nano- and micro/nano-scaffold [24,25], only one literature to date has reported a trimodal macro/micro/nanoporous scaffold for bone tissue engineering based on MBG [26].",
      "startOffset" : 230,
      "endOffset" : 234
    }, {
      "referenceID" : 26,
      "context" : "MBG scaffold (TMS) by a modified multi-template method involving ‘‘viscosity controlli Another clinical strategy to accelerate tissues regeneration is the incorporation of growth factors [27,28].",
      "startOffset" : 187,
      "endOffset" : 194
    }, {
      "referenceID" : 27,
      "context" : "MBG scaffold (TMS) by a modified multi-template method involving ‘‘viscosity controlli Another clinical strategy to accelerate tissues regeneration is the incorporation of growth factors [27,28].",
      "startOffset" : 187,
      "endOffset" : 194
    }, {
      "referenceID" : 28,
      "context" : "In particular, bone morphogenetic protein-2 (BMP-2), a potent osteoinductive growth factor, has been considered as the most notable cytokine to enhance bone formation [29,30].",
      "startOffset" : 167,
      "endOffset" : 174
    }, {
      "referenceID" : 29,
      "context" : "In particular, bone morphogenetic protein-2 (BMP-2), a potent osteoinductive growth factor, has been considered as the most notable cytokine to enhance bone formation [29,30].",
      "startOffset" : 167,
      "endOffset" : 174
    }, {
      "referenceID" : 33,
      "context" : ", and some researches have reported that the mesoporous support with comparable porous size to the protein molecule is beneficial for higher loading, preserved activity and sustained release [34,35].",
      "startOffset" : 191,
      "endOffset" : 198
    }, {
      "referenceID" : 34,
      "context" : ", and some researches have reported that the mesoporous support with comparable porous size to the protein molecule is beneficial for higher loading, preserved activity and sustained release [34,35].",
      "startOffset" : 191,
      "endOffset" : 198
    }, {
      "referenceID" : 8,
      "context" : "It’s well recognized that ‘‘Ca is loosely bound to the silica”, thus in a traditional soaking immobilization process, ‘‘during the immobilization of rhBMP-2, Ca ions would be largely released” [9,16].",
      "startOffset" : 193,
      "endOffset" : 199
    }, {
      "referenceID" : 15,
      "context" : "It’s well recognized that ‘‘Ca is loosely bound to the silica”, thus in a traditional soaking immobilization process, ‘‘during the immobilization of rhBMP-2, Ca ions would be largely released” [9,16].",
      "startOffset" : 193,
      "endOffset" : 199
    }, {
      "referenceID" : 33,
      "context" : "3A) indirectly suggested the entry of rhBMP-2 into mesopores of TMS [34,36], which was reconfirmed by the release behavior in Fig.",
      "startOffset" : 68,
      "endOffset" : 75
    }, {
      "referenceID" : 35,
      "context" : "3A) indirectly suggested the entry of rhBMP-2 into mesopores of TMS [34,36], which was reconfirmed by the release behavior in Fig.",
      "startOffset" : 68,
      "endOffset" : 75
    }, {
      "referenceID" : 36,
      "context" : "It’s worth noting that a leaf-like hydroxy-carbonate apatite crystal deposition, similar to the morphology of apatite in human bone [37,38], was extensively observed on the struts surface of TMS and BMS-M (Fig.",
      "startOffset" : 132,
      "endOffset" : 139
    }, {
      "referenceID" : 37,
      "context" : "S13) revealed a typical endochondral bone formation process [39,40].",
      "startOffset" : 60,
      "endOffset" : 67
    }, {
      "referenceID" : 38,
      "context" : "S13) revealed a typical endochondral bone formation process [39,40].",
      "startOffset" : 60,
      "endOffset" : 67
    }, {
      "referenceID" : 8,
      "context" : "Currently, there are mainly two methods for preparing 3D ordered MBG scaffolds with highly interconnected macropores: PU foam replication [41–43], and 3D printing technique [9,44].",
      "startOffset" : 173,
      "endOffset" : 179
    }, {
      "referenceID" : 42,
      "context" : "Currently, there are mainly two methods for preparing 3D ordered MBG scaffolds with highly interconnected macropores: PU foam replication [41–43], and 3D printing technique [9,44].",
      "startOffset" : 173,
      "endOffset" : 179
    }, {
      "referenceID" : 43,
      "context" : "repeated casting–squeezing–drying process results in discontinuity of each coating layer [45,46].",
      "startOffset" : 89,
      "endOffset" : 96
    }, {
      "referenceID" : 44,
      "context" : "repeated casting–squeezing–drying process results in discontinuity of each coating layer [45,46].",
      "startOffset" : 89,
      "endOffset" : 96
    }, {
      "referenceID" : 45,
      "context" : "One is the typical load transfer effect in particle reinforcing system [47,48].",
      "startOffset" : 71,
      "endOffset" : 78
    }, {
      "referenceID" : 46,
      "context" : "One is the typical load transfer effect in particle reinforcing system [47,48].",
      "startOffset" : 71,
      "endOffset" : 78
    }, {
      "referenceID" : 47,
      "context" : "It’s well recognized that debonding and cracking along the reinforcement/ matrix interface is one of the common fracture processes that occur in particle reinforcing systems [49], which could be avoided in the ‘‘homogeneous particle-reinforcing” system of MBG scaffold.",
      "startOffset" : 174,
      "endOffset" : 178
    }, {
      "referenceID" : 48,
      "context" : "In previous work, Hench proved that heating silica gel above 400 C could lead to the condensation of surface hydroxyl groups and formation a Si–O–Si network [50].",
      "startOffset" : 157,
      "endOffset" : 161
    }, {
      "referenceID" : 37,
      "context" : "According to the existing theories of endochondral bone formation [39,51], the regeneration process in this study could be divided into three stages: inflammation and cartilage formation (0–2 weeks), primary bone formation (2–4 weeks), and bone remodeling (after 4 weeks).",
      "startOffset" : 66,
      "endOffset" : 73
    }, {
      "referenceID" : 49,
      "context" : "According to the existing theories of endochondral bone formation [39,51], the regeneration process in this study could be divided into three stages: inflammation and cartilage formation (0–2 weeks), primary bone formation (2–4 weeks), and bone remodeling (after 4 weeks).",
      "startOffset" : 66,
      "endOffset" : 73
    }, {
      "referenceID" : 26,
      "context" : "Given that BMP-2 was reported to induce chemotaxis and chondrogenesis of MSCs at this stage [27,52], we first considered whether the difference came from different rhBMP-2 concentrations.",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 50,
      "context" : "Given that BMP-2 was reported to induce chemotaxis and chondrogenesis of MSCs at this stage [27,52], we first considered whether the difference came from different rhBMP-2 concentrations.",
      "startOffset" : 92,
      "endOffset" : 99
    }, {
      "referenceID" : 51,
      "context" : "However, without sustained release based on mesopores, the burst release of BMSM/rhBMP-2 not only deduced the utilization of the protein, but also brought carcinogenic and complication risks associated with excessive concentrations of rhBMP-2 [53,54].",
      "startOffset" : 243,
      "endOffset" : 250
    }, {
      "referenceID" : 52,
      "context" : "However, without sustained release based on mesopores, the burst release of BMSM/rhBMP-2 not only deduced the utilization of the protein, but also brought carcinogenic and complication risks associated with excessive concentrations of rhBMP-2 [53,54].",
      "startOffset" : 243,
      "endOffset" : 250
    }, {
      "referenceID" : 20,
      "context" : "By providing a larger surface area, the microporosities could facilitate the coprecipitation of endogenous cytokines and growth factor, which indirectly stimulate stem cells recruitment to the defect site [21,55].",
      "startOffset" : 205,
      "endOffset" : 212
    }, {
      "referenceID" : 53,
      "context" : "By providing a larger surface area, the microporosities could facilitate the coprecipitation of endogenous cytokines and growth factor, which indirectly stimulate stem cells recruitment to the defect site [21,55].",
      "startOffset" : 205,
      "endOffset" : 212
    }, {
      "referenceID" : 21,
      "context" : "During cartilage formation, newly formed collagen fibers mineralized and wrapped in the micropores forming tight interlock between material and tissue, resulting in a bone/scaffold composite with no ‘‘dead space” [22,56].",
      "startOffset" : 213,
      "endOffset" : 220
    }, {
      "referenceID" : 54,
      "context" : "During cartilage formation, newly formed collagen fibers mineralized and wrapped in the micropores forming tight interlock between material and tissue, resulting in a bone/scaffold composite with no ‘‘dead space” [22,56].",
      "startOffset" : 213,
      "endOffset" : 220
    }, {
      "referenceID" : 55,
      "context" : "Vascularization is the prerequisite of nutrition transportation for ossification at this stage [57,58].",
      "startOffset" : 95,
      "endOffset" : 102
    }, {
      "referenceID" : 56,
      "context" : "Vascularization is the prerequisite of nutrition transportation for ossification at this stage [57,58].",
      "startOffset" : 95,
      "endOffset" : 102
    }, {
      "referenceID" : 57,
      "context" : "Apart from its well-accepted osteoinductive capacity, rhBMP-2 was also reported to promote angiogenesis through stimulating the endogenous expression of VEGF [59,60].",
      "startOffset" : 158,
      "endOffset" : 165
    }, {
      "referenceID" : 58,
      "context" : "Apart from its well-accepted osteoinductive capacity, rhBMP-2 was also reported to promote angiogenesis through stimulating the endogenous expression of VEGF [59,60].",
      "startOffset" : 158,
      "endOffset" : 165
    }, {
      "referenceID" : 27,
      "context" : "As TMS/rhBMP-2 achieved an optimal regenerative performance without ‘‘dead space” in the first two stages, the matured osteoblasts and residual rhBMP-2 at the defect site could promote osteoclastogenesis as reported [28,61], thus further accelerated the remodeling process.",
      "startOffset" : 216,
      "endOffset" : 223
    }, {
      "referenceID" : 59,
      "context" : "As TMS/rhBMP-2 achieved an optimal regenerative performance without ‘‘dead space” in the first two stages, the matured osteoblasts and residual rhBMP-2 at the defect site could promote osteoclastogenesis as reported [28,61], thus further accelerated the remodeling process.",
      "startOffset" : 216,
      "endOffset" : 223
    }, {
      "referenceID" : 9,
      "context" : "Throughout this whole process, interconnected macropores, as the basic structural support for bone regeneration, could ensure nutrition transportation, promote vascularization, and provide space for ingrowth of new vessels and bone tissue [10,62].",
      "startOffset" : 239,
      "endOffset" : 246
    }, {
      "referenceID" : 60,
      "context" : "Throughout this whole process, interconnected macropores, as the basic structural support for bone regeneration, could ensure nutrition transportation, promote vascularization, and provide space for ingrowth of new vessels and bone tissue [10,62].",
      "startOffset" : 239,
      "endOffset" : 246
    }, {
      "referenceID" : 37,
      "context" : "And BMP-2, as the key factor that is expressed throughout the bone regeneration process, serves various functions at different stages [39,51].",
      "startOffset" : 134,
      "endOffset" : 141
    }, {
      "referenceID" : 49,
      "context" : "And BMP-2, as the key factor that is expressed throughout the bone regeneration process, serves various functions at different stages [39,51].",
      "startOffset" : 134,
      "endOffset" : 141
    } ],
    "year" : 2016,
    "abstractText" : "http://dx.doi.org/10.1016/j.actbio.2015.12.006 1742-7061/ 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. ⇑ Corresponding authors. Address: Engineering Research Center for Biomaterials of Ministry of Education, East China University of Science and Technology, Shanghai 200237, PR China. E-mail addresses: yyuan@ecust.edu.cn (Y. Yuan), liucs@ecust.edu.cn (C. Liu). Wei Tang , Dan Lin , Yuanman Yu , Haoyi Niu , Han Guo , Yuan Yuan c,⇑, Changsheng Liu a,b,c,⇑",
    "creator" : "Elsevier"
  }
}